{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:34:31Z","timestamp":1754195671829,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:00:00Z","timestamp":1586736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:00:00Z","timestamp":1586736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s40256-020-00406-0","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T01:02:31Z","timestamp":1586739751000},"page":"217-221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19"],"prefix":"10.1007","volume":"20","author":[{"given":"Chia Siang","family":"Kow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Tabish Razi","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4058-2215","authenticated-orcid":false,"given":"Syed Shahzad","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,13]]},"reference":[{"key":"406_CR1","doi-asserted-by":"publisher","unstructured":"Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. https:\/\/doi.org\/10.1016\/S1473-3099(20)30120-1(epub 19 Feb 2020)","DOI":"10.1016\/S1473-3099(20)30120-1"},{"issue":"7798","key":"406_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270\u20133.","journal-title":"Nature"},{"key":"406_CR3","doi-asserted-by":"crossref","unstructured":"Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631\u2013637.","DOI":"10.1002\/path.1570"},{"issue":"17","key":"406_CR4","doi-asserted-by":"publisher","first-page":"14838","DOI":"10.1074\/jbc.M200581200","volume":"277","author":"C Vickers","year":"2002","unstructured":"Vickers C, Hales P, Kaushik V, et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem. 2002;277(17):14838\u201343.","journal-title":"J Biol Chem"},{"key":"406_CR5","doi-asserted-by":"publisher","unstructured":"Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2002032(epub 28 Feb 2020)","DOI":"10.1056\/NEJMoa2002032"},{"key":"406_CR6","doi-asserted-by":"publisher","unstructured":"Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. https:\/\/doi.org\/10.1111\/all.14238(epub 19 Feb 2020)","DOI":"10.1111\/all.14238"},{"key":"406_CR7","doi-asserted-by":"crossref","unstructured":"Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. (published correction appears in Lancet, epub 12 Mar 2020)(epub 11 Mar 2020)","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"406_CR8","doi-asserted-by":"publisher","unstructured":"Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. https:\/\/doi.org\/10.1001\/jamainternmed.2020.0994(epub 13 Mar 2020)","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"406_CR9","doi-asserted-by":"publisher","unstructured":"Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2020.0950(epub 25 Mar 2020)","DOI":"10.1001\/jamacardio.2020.0950"},{"key":"406_CR10","doi-asserted-by":"publisher","unstructured":"Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2020.1017(epub 27 Mar 2020)","DOI":"10.1001\/jamacardio.2020.1017"},{"key":"406_CR11","doi-asserted-by":"publisher","unstructured":"Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. https:\/\/doi.org\/10.1038\/s41569-020-0360-5(epub 5 Mar 2020)","DOI":"10.1038\/s41569-020-0360-5"},{"key":"406_CR12","doi-asserted-by":"crossref","unstructured":"Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. (epub 11 Mar 2020)","DOI":"10.1016\/S2213-2600(20)30116-8"},{"issue":"5","key":"406_CR13","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","volume":"43","author":"Y Ishiyama","year":"2004","unstructured":"Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension. 2004;43(5):970\u20136.","journal-title":"Hypertension"},{"issue":"4","key":"406_CR14","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/01.HYP.0000237862.94083.45","volume":"48","author":"MP Ocaranza","year":"2006","unstructured":"Ocaranza MP, Godoy I, Jalil JE, et al. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat. Hypertension. 2006;48(4):572\u20138.","journal-title":"Hypertension"},{"issue":"2","key":"406_CR15","doi-asserted-by":"publisher","first-page":"F398","DOI":"10.1152\/ajprenal.90488.2008","volume":"296","author":"MJ Soler","year":"2009","unstructured":"Soler MJ, Ye M, Wysocki J, William J, Lloveras J, Batlle D. Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan. Am J Physiol Renal Physiol. 2009;296(2):F398\u2013F405.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"20","key":"406_CR16","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","volume":"111","author":"CM Ferrario","year":"2005","unstructured":"Ferrario CM, Jessup J, Chappell MC, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111(20):2605\u201310.","journal-title":"Circulation"},{"issue":"1\u20133","key":"406_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.regpep.2010.09.005","volume":"166","author":"JC Zhong","year":"2011","unstructured":"Zhong JC, Ye JY, Jin HY, et al. Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression. Regul Pept. 2011;166(1\u20133):90\u20137.","journal-title":"Regul Pept"},{"issue":"8","key":"406_CR18","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1111\/jcmm.12573","volume":"19","author":"J Klimas","year":"2015","unstructured":"Klimas J, Olvedy M, Ochodnicka-Mackovicova K, et al. Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats. J Cell Mol Med. 2015;19(8):1965\u201374.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"406_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","volume":"26","author":"LM Burrell","year":"2005","unstructured":"Burrell LM, Risvanis J, Kubota E, et al. Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J. 2005;26(4):369\u201324.","journal-title":"Eur Heart J"},{"issue":"11","key":"406_CR20","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1042\/CS20120162","volume":"123","author":"LJ Burchill","year":"2012","unstructured":"Burchill LJ, Velkoska E, Dean RG, Griggs K, Patel SK, Burrell LM. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions. Clin Sci (Lond). 2012;123(11):649\u201358.","journal-title":"Clin Sci (Lond)"},{"issue":"8","key":"406_CR21","first-page":"1280","volume":"19","author":"TE Walters","year":"2017","unstructured":"Walters TE, Kalman JM, Patel SK, Mearns M, Velkoska E, Burrell LM. Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling. Europace. 2017;19(8):1280\u20137.","journal-title":"Europace"},{"issue":"6","key":"406_CR22","doi-asserted-by":"publisher","first-page":"e0198144","DOI":"10.1371\/journal.pone.0198144","volume":"13","author":"J Ramchand","year":"2018","unstructured":"Ramchand J, Patel SK, Srivastava PM, Farouque O, Burrell LM. Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease. PLoS ONE. 2018;13(6):e0198144.","journal-title":"PLoS ONE"},{"issue":"7","key":"406_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cardfail.2009.01.014","volume":"15","author":"S Epelman","year":"2009","unstructured":"Epelman S, Shrestha K, Troughton RW, et al. Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes. J Card Fail. 2009;15(7):565\u201371.","journal-title":"J Card Fail"},{"issue":"3","key":"406_CR24","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jcmg.2019.09.005","volume":"13","author":"J Ramchand","year":"2020","unstructured":"Ramchand J, Patel SK, Kearney LG, et al. Plasma ACE2 activity predicts mortality in aortic stenosis and is associated with severe myocardial fibrosis. JACC Cardiovasc Imaging. 2020;13(3):655\u201364.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"406_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/ajh\/hpu086","volume":"28","author":"M Furuhashi","year":"2015","unstructured":"Furuhashi M, Moniwa N, Mita T, et al. Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker. Am J Hypertens. 2015;28(1):15\u2013211.","journal-title":"Am J Hypertens"},{"issue":"4","key":"406_CR26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00726-014-1889-6","volume":"47","author":"RN Vuille-dit-Bille","year":"2015","unstructured":"Vuille-dit-Bille RN, Camargo SM, Emmenegger L, et al. Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors. Amino Acids. 2015;47(4):693\u2013705.","journal-title":"Amino Acids"},{"issue":"7","key":"406_CR27","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1080\/10641963.2018.1529782","volume":"41","author":"M Hristova","year":"2019","unstructured":"Hristova M, Stanilova S, Miteva L. Serum concentration of renin-angiotensin system components in association with ACE I\/D polymorphism among hypertensive subjects in response to ACE inhibitor therapy. Clin Exp Hypertens. 2019;41(7):662\u20139.","journal-title":"Clin Exp Hypertens"},{"issue":"4","key":"406_CR28","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.2353\/ajpath.2007.061088","volume":"170","author":"J Gu","year":"2007","unstructured":"Gu J, Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol. 2007;170(4):1136\u201347.","journal-title":"Am J Pathol"},{"issue":"8","key":"406_CR29","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11(8):875\u20139.","journal-title":"Nat Med"},{"issue":"7047","key":"406_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Y Imai","year":"2005","unstructured":"Imai Y, Kuba K, Rao S, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112\u20136.","journal-title":"Nature"},{"issue":"1","key":"406_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s13054-017-1882-z","volume":"21","author":"H Zhang","year":"2017","unstructured":"Zhang H, Baker A. Recombinant human ACE2: acing out angiotensin II in ARDS therapy. Crit Care. 2017;21(1):305.","journal-title":"Crit Care"},{"issue":"3","key":"406_CR32","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","volume":"63","author":"Y Liu","year":"2020","unstructured":"Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364\u201374.","journal-title":"Sci China Life Sci"},{"issue":"5","key":"406_CR33","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1161\/CIRCHEARTFAILURE.108.840124","volume":"2","author":"Z Kassiri","year":"2009","unstructured":"Kassiri Z, Zhong J, Guo D, et al. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction. Circ Heart Fail. 2009;2(5):446\u201355.","journal-title":"Circ Heart Fail"},{"issue":"7","key":"406_CR34","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","volume":"39","author":"GY Oudit","year":"2009","unstructured":"Oudit GY, Kassiri Z, Jiang C, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009;39(7):618\u201325.","journal-title":"Eur J Clin Invest"},{"key":"406_CR35","unstructured":"Peng YD, Meng K, Guan HQ, et al. Clinical features and outcome of 112 cases of novel coronavirus pneumonia in cardiovascular patients (in Chinese). Chin J Cardiol. 2020;48."},{"key":"406_CR36","doi-asserted-by":"publisher","unstructured":"Yang G, Tan Z, Zhou L, et al. Angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors usage is associated with improved inflammatory status and clinical outcomes in COVID-19 patients with hypertension. medRxiv 2020. https:\/\/doi.org\/10.1101\/2020.03.31.20038935","DOI":"10.1101\/2020.03.31.20038935"},{"issue":"2","key":"406_CR37","doi-asserted-by":"publisher","first-page":"e004675","DOI":"10.1161\/JAHA.116.004675","volume":"6","author":"LG Gilstrap","year":"2017","unstructured":"Gilstrap LG, Fonarow GC, Desai AS, et al. Initiation, continuation, or withdrawal of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers and outcomes in patients hospitalized with heart failure with reduced ejection fraction. J Am Heart Assoc. 2017;6(2):e004675.","journal-title":"J Am Heart Assoc"},{"key":"406_CR38","doi-asserted-by":"crossref","unstructured":"Pflugfelder PW, Baird MG, Tonkon MJ, DiBianco R, Pitt B. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators. J Am Coll Cardiol. 1993;22(6):1557\u20131563.","DOI":"10.1016\/0735-1097(93)90578-O"},{"issue":"2","key":"406_CR39","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/ALN.0000000000000739","volume":"123","author":"SM Lee","year":"2015","unstructured":"Lee SM, Takemoto S, Wallace AW. Association between withholding angiotensin receptor blockers in the early postoperative period and 30-day mortality: a cohort study of the Veterans Affairs Healthcare System. Anesthesiology. 2015;123(2):288\u2013306.","journal-title":"Anesthesiology"},{"issue":"5","key":"406_CR40","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/jhm.2182","volume":"9","author":"SC Mudumbai","year":"2014","unstructured":"Mudumbai SC, Takemoto S, Cason BA, Au S, Upadhyay A, Wallace AW. Thirty-day mortality risk associated with the postoperative nonresumption of angiotensin-converting enzyme inhibitors: a retrospective study of the Veterans Affairs Healthcare System. J Hosp Med. 2014;9(5):289\u201396.","journal-title":"J Hosp Med"},{"key":"406_CR41","unstructured":"Sparks MA, Hiremath S, et al. The Coronavirus Conundrum: ACE2 and hypertension edition. NephJC. https:\/\/www.nephjc.com\/news\/covidace2. Accessed 5 Apr 2020."},{"key":"406_CR42","unstructured":"Coronavirus ACEi\/ARB Investigation (CORONACION). ClinicalTrials.gov identifier NCT04330300. Bethesda (MD): National Library of Medicine (US); 1 Apr 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04330300. Accessed 5 Apr 2020."}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-020-00406-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-020-00406-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-020-00406-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T03:16:23Z","timestamp":1666322183000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-020-00406-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,13]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["406"],"URL":"https:\/\/doi.org\/10.1007\/s40256-020-00406-0","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"type":"print","value":"1175-3277"},{"type":"electronic","value":"1179-187X"}],"subject":[],"published":{"date-parts":[[2020,4,13]]},"assertion":[{"value":"13 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No external funding was used in the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Chia Siang Kow, Syed Tabish Razi Zaidi, and Syed Shahzad Hasan declare that they have no potential conflicts of interest that might be relevant to this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}